{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T12:02:33Z","timestamp":1793275353236,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurosci"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>We have shown previously that near-infrared light (NIr) treatment or photobiomodulation neuroprotects dopaminergic cells in substantia nigra pars compacta (SNc) from degeneration induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in Balb\/c albino mice, a well-known model for Parkinson\u2019s disease. The present study explores whether NIr treatment offers neuroprotection to these cells in C57BL\/6 pigmented mice. In addition, we examine whether NIr influences behavioural activity in both strains after MPTP treatment. We tested for various locomotive parameters in an open-field test, namely velocity, high mobility and immobility.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Balb\/c (albino) and C57BL\/6 (pigmented) mice received injections of MPTP (total of 50\u00a0mg\/kg) or saline and NIr treatments (or not) over 48\u00a0hours. After each injection and\/or NIr treatment, the locomotor activity of the mice was tested. After six days survival, brains were processed for TH (tyrosine hydroxylase) immunochemistry and the number of TH<jats:sup>+<\/jats:sup> cells in the substantia nigra pars compacta (SNc) was estimated using stereology. Results showed higher numbers of TH<jats:sup>+<\/jats:sup> cells in the MPTP-NIr groups of both strains, compared to the MPTP groups, with the protection greater in the Balb\/c mice (30% vs 20%). The behavioural tests revealed strain differences also. For Balb\/c mice, the MPTP-NIr group showed greater preservation of locomotor activity than the MPTP group. Behavioural preservation was less evident in the C57BL\/6 strain however, with little effect of NIr being recorded in the MPTP-treated cases of this strain. Finally, there were differences between the two strains in terms of NIr penetration across the skin and fur. Our measurements indicated that NIr penetration was considerably less in the pigmented C57BL\/6, compared to the albino Balb\/c mice.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>In summary, our results revealed the neuroprotective benefits of NIr treatment after parkinsonian insult at both cellular and behavioural levels and suggest that Balb\/c strain, due to greater penetration of NIr through skin and fur, provides a clearer model of protection than the C57BL\/6 strain.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2202-14-40","type":"journal-article","created":{"date-parts":[[2013,3,27]],"date-time":"2013-03-27T07:14:33Z","timestamp":1364368473000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":68,"title":["Photobiomodulation preserves behaviour and midbrain dopaminergic cells from MPTP toxicity: evidence from two mouse strains"],"prefix":"10.1186","volume":"14","author":[{"given":"C\u00e9cile","family":"Moro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Napoleon","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabil","family":"El Massri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Ratel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel M","family":"Johnstone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Mitrofanis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alim-Louis","family":"Benabid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,3,27]]},"reference":[{"key":"2873_CR1","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0301-0082(99)00067-2","volume":"2","author":"F Blandini","year":"2000","unstructured":"Blandini F, Nappi G, Tassorelli C, Martignoni E: Functional changes of the basal ganglia circuitry in Parkinson\u2019s disease. Prog Neurobiol. 2000, 2: 63-88.","journal-title":"Prog Neurobiol"},{"key":"2873_CR2","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1002\/mds.10140","volume":"17","author":"H Bergman","year":"2002","unstructured":"Bergman H, Deuschl G: Pathophysiology of Parkinson\u2019s disease: from clinical neurology to basic neuroscience and back. Mov Disord. 2002, 17: S28-S40. 10.1002\/mds.10140.","journal-title":"Mov Disord"},{"key":"2873_CR3","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.1002\/mds.870080507","volume":"1","author":"JO Rinne","year":"1993","unstructured":"Rinne JO: Nigral degeneration in Parkinson\u2019s disease. Mov Disord 8 Suppl. 1993, 1: S31-S35.","journal-title":"Mov Disord 8 Suppl"},{"key":"2873_CR4","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1006\/exnr.1997.6418","volume":"144","author":"DA McRitchie","year":"1997","unstructured":"McRitchie DA, Cartwright HR, Halliday GM: Specific A10 dopaminergic nuclei in the midbrain degenerate in Parkinson\u2019s disease. Exp Neurol. 1997, 144: 202-213. 10.1006\/exnr.1997.6418.","journal-title":"Exp Neurol"},{"key":"2873_CR5","doi-asserted-by":"publisher","first-page":"S153","DOI":"10.1212\/WNL.47.6_Suppl_3.153S","volume":"47","author":"JW Langston","year":"1996","unstructured":"Langston JW: The etiology of Parkinson\u2019s disease with emphasis on the MPTP story. Neurology. 1996, 47: S153-S160. 10.1212\/WNL.47.6_Suppl_3.153S.","journal-title":"Neurology"},{"key":"2873_CR6","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/ng0298-106","volume":"18","author":"R Kruger","year":"1998","unstructured":"Kruger R, Kuhn W, Muller T, Woitalla D, Graeber M, Kosel S, Przuntek H, Epplen JT, Schols L, Riess O: Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson\u2019s disease. Nat Genet. 1998, 18: 106-118. 10.1038\/ng0298-106.","journal-title":"Nat Genet"},{"key":"2873_CR7","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/978-3-211-33328-0_13","volume":"71","author":"PA LeWitt","year":"2006","unstructured":"LeWitt PA: Neuroprotection for Parkinson\u2019s disease. J Neural Transm Suppl. 2006, 71: 113-122. 10.1007\/978-3-211-33328-0_13.","journal-title":"J Neural Transm Suppl"},{"key":"2873_CR8","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.parkreldis.2008.07.008","volume":"15","author":"J Ma","year":"2009","unstructured":"Ma J, Shaw VE, Mitrofanis J: Does melatonin help save dopaminergic cells in MPTP-treated mice?. Parkinsonism Relat Disord. 2009, 15: 307-314. 10.1016\/j.parkreldis.2008.07.008.","journal-title":"Parkinsonism Relat Disord"},{"key":"2873_CR9","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.neuroscience.2008.03.042","volume":"153","author":"HL Liang","year":"2008","unstructured":"Liang HL, Whelan HT, Eells JT, Wong-Riley MT: Near-infrared light via light-emitting diode treatment is therapeutic against rotenone- and 1-methyl-4-phenylpyridinium ion-induced neurotoxicity. Neurosci. 2008, 153: 963-974. 10.1016\/j.neuroscience.2008.03.042.","journal-title":"Neurosci"},{"key":"2873_CR10","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.brainres.2008.09.057","volume":"1243","author":"R Ying","year":"2008","unstructured":"Ying R, Liang HL, Whelan HT, Eells JT, Wong-Riley MT: Pretreatment with near-infrared light via light-emitting diode provides added benefit against rotenone - and MPP+- induced neurotoxicity. Brain Res. 2008, 1243: 167-173.","journal-title":"Brain Res"},{"key":"2873_CR11","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/cne.22207","volume":"1518","author":"VE Shaw","year":"2010","unstructured":"Shaw VE, Spana S, Ashkan K, Benabid AL, Stone J, Baker GE, Mitrofanis J: Neuroprotection of midbrain dopaminergic cells in MPTP-treated mice after near-infrared light treatment. J Comp Neurol. 2010, 1518: 25-40.","journal-title":"J Comp Neurol"},{"key":"2873_CR12","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.parkreldis.2012.01.005","volume":"18","author":"CL Peoples","year":"2012","unstructured":"Peoples CL, Spana S, Ashkan K, Benabid AL, Stone J, Baker GE, Mitrofanis J: Photobiomodulation enhances nigral dopaminergic cell survival in a chronic MPTP mouse model of Parkinson\u2019s disease. Parkinsonism Relat Disord. 2012, 18: 469-476. 10.1016\/j.parkreldis.2012.01.005.","journal-title":"Parkinsonism Relat Disord"},{"key":"2873_CR13","first-page":"1","volume-title":"SPIE Newsroom","author":"HT Whelan","year":"2008","unstructured":"Whelan HT, DeSmet KD, Buchmann E, Henry M, Wong-Riley M, Eells JT, Verhoeve J: Harnessing the cell\u2019s own ability to repair and prevent neurodegenerative disease. SPIE Newsroom. 2008, 1-3. 10.1117\/2.1200801.1014."},{"key":"2873_CR14","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1089\/pho.2006.24.121","volume":"24","author":"KD Desmet","year":"2006","unstructured":"Desmet KD, Paz DA, Corry JJ, Eells JT, Wong-Riley MT, Henry MM, Buchmann EV, Connelly MP, Dovi JV, Liang HL, Henshel DS, Yeager RL, Millsap DS, Lim J, Gould LJ, Das R, Jett M, Hodgson BD, Margolis D, Whelan HT: Clinical and experimental applications of NIR-LED photobiomodulation. Photomed Laser Surg. 2006, 24: 121-128. 10.1089\/pho.2006.24.121.","journal-title":"Photomed Laser Surg"},{"key":"2873_CR15","first-page":"6140","volume-title":"Mechanisms for low-light therapy","author":"MR Hamblin","year":"2006","unstructured":"Hamblin MR, Demidova TN: Mechanisms of low level light therapy. Mechanisms for low-light therapy. Edited by: Hamblin MR, Waynart RW, Anders J. 2006, San Jose, CA, USA: Proc SPIE, 6140."},{"key":"2873_CR16","doi-asserted-by":"crossref","unstructured":"Shaw VE, Peoples CL, Spana S, Ashkan K, Benabid AL, Stone J, Baker GE, Mitrofanis J: Patterns of cell activity in the subthalamic region associated with the neuroprotective action of near-infrared light treatment in MPTP-treated mice. Parkinson\u2019s disease. 2012, ID 296875","DOI":"10.1155\/2012\/296875"},{"key":"2873_CR17","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1023\/A:1001958023096","volume":"30","author":"M Sedelis","year":"2000","unstructured":"Sedelis M, Hofele K, Auburger GW, Morgan S, Huston JP, Schwarting RKW: MPTP Susceptibility in the Mouse: Behavioural, Neurochemical, and Histological Analysis of Gender and Strain Differences. Behav Gen. 2000, 30: 171-182. 10.1023\/A:1001958023096.","journal-title":"Behav Gen"},{"key":"2873_CR18","volume-title":"Exp Toxic Path","author":"T Ito","year":"2011","unstructured":"Ito T, Suzuki K, Uchida K, Nakayama H: Different susceptibility to 1-methyl-4-phenylpyridium (MPP+)-induced nigro-striatal dopaminergic cell loss between C57BL\/6 and BALB\/c mice is not related to the difference of monoamine oxidase-B (MAO-B). Exp Toxic Path. 2011, EPub"},{"key":"2873_CR19","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/0006-8993(91)90854-O","volume":"555","author":"NJ Riachi","year":"1991","unstructured":"Riachi NJ, Behmand RA, Harik SI: Correlation of MPTP neurotoxicity in vivo with oxidation of MPTP by the brain and blood\u2013brain barrier in vitro in five rat strains. Brain Res. 1991, 555: 19-24. 10.1016\/0006-8993(91)90854-O.","journal-title":"Brain Res"},{"key":"2873_CR20","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s00441-004-0938-y","volume":"318","author":"A Schober","year":"2004","unstructured":"Schober A: Classic toxin-induced animal models of Parkinson\u2019s disease: 6OHDA and MPTP. Cell Tissue Res. 2004, 318: 215-24. 10.1007\/s00441-004-0938-y.","journal-title":"Cell Tissue Res"},{"key":"2873_CR21","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.neuroscience.2011.10.057","volume":"211","author":"J Bov\u00e9","year":"2012","unstructured":"Bov\u00e9 J, Perier C: Neurotoxin-based models of Parkinson\u2019s disease. Neurosci. 2012, 211: 51-76.","journal-title":"Neurosci"},{"key":"2873_CR22","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1111\/j.1460-9568.1996.tb01603.x","volume":"8","author":"B Piallat","year":"1996","unstructured":"Piallat B, Benazzouz A, Benabid AL: Subthalamic nucleus lesion in rats prevents dopaminergic nigral neuron degeneration after striatal 6-OHDA injection: behavioural and immunohistochemical studies. Eur J Neurosci. 1996, 8: 1408-1414. 10.1111\/j.1460-9568.1996.tb01603.x.","journal-title":"Eur J Neurosci"},{"key":"2873_CR23","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/brain\/awm137","volume":"130","author":"BA Wallace","year":"2007","unstructured":"Wallace BA, Ashkan K, Heise CE, Foote KD, Torres N, Mitrofanis J, Benabid AL: Survival of midbrain dopaminergic cells after lesion or deep brain stimulation of the subthalamic nucleus in MPTP-treated monkeys. Brain. 2007, 130: 2129-2145. 10.1093\/brain\/awm137.","journal-title":"Brain"},{"key":"2873_CR24","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.parkreldis.2007.08.010","volume":"14","author":"N Luquin","year":"2008","unstructured":"Luquin N, Mitrofanis J: Does the cerebral cortex exacerbate dopamineric cell death in the substantia nigra of 6OHDA-lesioned rats?. Parkinson Related Disord. 2008, 14: 213-223. 10.1016\/j.parkreldis.2007.08.010.","journal-title":"Parkinson Related Disord"},{"key":"2873_CR25","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1006\/nbdi.1997.0151","volume":"4","author":"A Bj\u00f6rklund","year":"1997","unstructured":"Bj\u00f6rklund A, Rosenblad C, Winkler C, Kirik D: Studies on neuroprotective and regenerative effects of GDNF in a partial lesion model of Parkinson\u2019s disease. Neurobiol Dis. 1997, 4: 186-200. 10.1006\/nbdi.1997.0151.","journal-title":"Neurobiol Dis"},{"key":"2873_CR26","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1093\/brain\/awl332","volume":"130","author":"P Huot","year":"2007","unstructured":"Huot P, L\u00e9vesque M, Parent A: The fate of striatal dopaminergic neurons in Parkinson\u2019s disease and Huntington\u2019s chorea. Brain. 2007, 130: 222-32.","journal-title":"Brain"},{"key":"2873_CR27","volume-title":"The mouse brain in stereotaxic coordinates","author":"G Paxinos","year":"2001","unstructured":"Paxinos G, Franklin BJ: The mouse brain in stereotaxic coordinates. 2001, San Diego, CA, USA: Academic Press California USA, 2","edition":"2"},{"key":"2873_CR28","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1006\/exnr.1997.6648","volume":"148","author":"E Bezard","year":"1997","unstructured":"Bezard E, Dovero S, Bioulac B, Gross C: Effects of different schedules of MPTP administration on dopaminergic neurodegeneration in mice. Exp Neurol. 1997, 148: 288-292. 10.1006\/exnr.1997.6648.","journal-title":"Exp Neurol"},{"key":"2873_CR29","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.neuroscience.2011.02.027","volume":"180","author":"NR Goldberg","year":"2011","unstructured":"Goldberg NR, Haack AK, Lim NS, Janson OK, Meshul CK: Dopaminergic and behavioural correlates of progressive lesioning of the nigrostriatal pathway with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neurosci. 2011, 180: 256-271.","journal-title":"Neurosci"},{"key":"2873_CR30","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1039\/B511922G","volume":"2","author":"P Meredith","year":"2006","unstructured":"Meredith P, Powell BJ, Riesz J, Nighswander-Rempel S, Pederson MR, Moore E: Towards structure\u2013property-function relationships for eumelanin. Soft Matter. 2006, 2: 37.","journal-title":"Soft Matter"}],"container-title":["BMC Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2202-14-40.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T22:49:15Z","timestamp":1630536555000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurosci.biomedcentral.com\/articles\/10.1186\/1471-2202-14-40"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,27]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["2873"],"URL":"https:\/\/doi.org\/10.1186\/1471-2202-14-40","relation":{},"ISSN":["1471-2202"],"issn-type":[{"value":"1471-2202","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,27]]},"assertion":[{"value":"26 October 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"40"}}